Preparation method of 4-chloro-3-(4-ethoxybenzyl)benzaldehyde
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI SUN SAIL PHARMA SCI & TECH CO LTD
- Publication Date
- 2014-07-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a preparation method of a compound, in particular to a sodium-dependent glucose transporter 2 (SGLT-2) inhibitor Ertugliflozin key intermediate 4-chloro-3-(4-ethoxybenzyl)benzene A new preparation method of formaldehyde [compound of formula (I)].
[0002] Background technique
[0003] Type 2 diabetes is a group of clinical syndromes characterized by chronic hyperglycemia due to insufficient insulin secretion or insulin resistance leading to carbohydrate, fat and protein abnormalities. greater than 130mg / dL) and diabetes.
[0004] In a healthy human body, more than 99% of blood sugar is reabsorbed back into the blood after being filtered by the glomerulus, and less than 1% of the blood sugar is excreted into the urine. This process is completed by the sodium-dependent glucose transporter (SGLT-1 / 2). SGLT-1 with high affinity and low transport capacity is mainly distributed in the stomach, heart and kidney (completes...